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Identification of Components of the Host Type IA Phosphoinositide
3-Kinase Pathway That Promote Internalization of
Listeria monocytogenes
Shahanawaz Jiwani,a Yi Wang,b Georgina C. Dowd,b Antonella Gianfelice,b Phannipha Pichestapong,c Balramakrishna Gavicherla,a
Neyda Vanbennekom,a and Keith Iretonb
Department of Molecular Biology and Microbiology, College of Medicine, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida, USAa;
Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealandb; and The Australian National University, Research School of Biology,
Canberra, Australiac

The bacterial pathogen Listeria monocytogenes causes food-borne illnesses resulting in gastroenteritis, meningitis, or abortion.
Listeria promotes its internalization into some human cells through binding of the bacterial surface protein InlB to the host receptor tyrosine kinase Met. The interaction of InlB with the Met receptor stimulates host signaling pathways that promote cell
surface changes driving bacterial uptake. One human signaling protein that plays a critical role in Listeria entry is type IA phosphoinositide 3-kinase (PI 3-kinase). The molecular mechanism by which PI 3-kinase promotes bacterial internalization is not
understood. Here we perform an RNA interference (RNAi)-based screen to identify components of the type IA PI 3-kinase pathway that control the entry of Listeria into the human cell line HeLa. The 64 genes targeted encode known upstream regulators or
downstream effectors of type IA PI 3-kinase. The results of this screen indicate that at least 9 members of the PI 3-kinase pathway play important roles in Listeria uptake. These 9 human proteins include a Rab5 GTPase, several regulators of Arf or Rac1
GTPases, and the serine/threonine kinases phosphoinositide-dependent kinase 1 (PDK1), mammalian target of rapamycin
(mTor), and protein kinase C-. These findings represent a key first step toward understanding the mechanism by which type IA
PI 3-kinase controls bacterial internalization.

L

isteria monocytogenes is a food-borne bacterial pathogen capable of causing severe infections culminating in meningitis or
abortion (70, 84). Listeria induces its own internalization (“entry”) into host cells that are normally nonphagocytic. The entry of
Listeria into enterocytes and hepatocytes plays an important role
in virulence by allowing bacteria to traverse the intestinal barrier
(6, 44) and to colonize the liver (29). Another potential role for
Listeria internalization is infection of the placenta (6), although
this idea is controversial (89).
One of the major pathways of Listeria entry into host epithelial
cells is mediated by the interaction of the bacterial surface protein
InlB with its host receptor, the Met receptor tyrosine kinase (44,
78). InlB binds directly to the extracellular domain of Met, resulting in activation (tyrosine phosphorylation) of the receptor. Once
activated, Met promotes signal transduction events that remodel
the host cell surface, leading to bacterial engulfment (4, 5, 24, 45,
85). Host surface remodeling is driven, at least in part, by localized
polymerization of actin. One of the human signaling proteins that
acts downstream of Met to stimulate F-actin assembly and the
internalization of Listeria is type IA phosphoinositide 3-kinase (PI
3-kinase). Listeria infection induces localized activation of PI
3-kinase (24, 45). Genetic or pharmacological inhibition of type
IA PI 3-kinase results in a reduction in InlB-mediated actin
polymerization and bacterial entry (24, 45, 46). The molecular
mechanism by which PI 3-kinase promotes Listeria internalization is not known.
Type IA PI 3-kinase is a heterodimeric enzyme composed of a
110-kDa catalytic subunit and an 85-kDa regulatory subunit (31).
This PI 3-kinase controls a variety of processes in mammalian
cells, including cell growth, survival, and motility. Type IA PI
3-kinase promotes its biological effects through at least two mech-
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anisms. The best-understood mechanism involves lipid kinase
activity. PI 3-kinase produces phosphatidylinositol 3,4,5trisphosphate [PI(3,4,5)P3], a lipid second messenger that
binds a plethora of downstream “target” proteins (11, 31).
PI(3,4,5)P3 recruits these target proteins to the plasma membrane,
where they exert their biological activities. PI(3,4,5)P3 is converted by phosphatases to phosphatidylinositol 3,4-bisphosphate
[PI(3,4)P2], another lipid with signaling activity (11, 31). Apart
from producing lipid second messengers, type IA PI 3-kinase can
also regulate signal transduction through protein-protein interactions (15, 18, 40, 52).
In order to understand how type IA PI 3-kinase promotes the
internalization of Listeria, it is critical to identify human proteins
that act upstream and downstream of this kinase to control pathogen uptake. In this work, we describe an RNA interference
(RNAi)-based genetic screen to identify components of the type
IA PI 3-kinase signaling pathway involved in Listeria uptake. The
64 host genes targeted in this screen encode proteins that bind
PI(3,4,5)P3 and/or PI(3,4)P2, proteins that interact with catalytic
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or regulatory subunits of PI 3-kinase, and proteins that are indirectly regulated by PI 3-kinase. Our findings indicate that at least
nine human genes known to participate in type IA PI 3-kinase
signaling are involved in Listeria entry. This work is an important
first step in dissecting the molecular mechanism by which type IA
PI 3-kinase mediates bacterial internalization.
MATERIALS AND METHODS
Bacterial strains, mammalian cell lines, and media. The Listeria monocytogenes strain BUG 947 was used for these studies. BUG 947 contains an
in-frame deletion in the inlA gene and has normal expression of InlB (29).
Consequently, BUG 947 is incapable of infecting HeLa or other host
cells through interaction of the Listeria surface protein InlA with its
host receptor, E-cadherin (24, 59, 78). Instead, this bacterial strain
enters into host cells in a manner dependent on InlB and its host
receptor, Met (24, 45, 78). The Listeria strain was grown in brain heart
infusion (BHI; Difco) broth and was prepared for infection as described previously (46).
The human epithelial cell line HeLa (ATTC CCL-2) was grown in
Dulbecco’s modified Eagle’s medium (DMEM) with 4.5 g of glucose per
liter and 2 mM glutamine (catalog no. 11995-065; Invitrogen), supplemented with 10% fetal bovine serum (FBS). Cell growth, cell stimulation,
and bacterial infections were performed at 37°C under 5% CO2.
siRNAs. The sequences of short interfering RNAs (siRNAs) used to
target the human genes in the host type IA PI 3-kinase pathway are
listed in Table S1 in the supplemental material. These siRNAs were
designed by, and purchased from, Ambion or Sigma-Aldrich. As negative controls, two “nontargeting” siRNAs were used. These control
siRNAs (nontargeting control 1 [catalog no. D-001210-01; Dharmacon] or nontargeting control 2 [catalog no. SIC001; Sigma-Aldrich])
contain two or more mismatches with all sequences in the human
genome. Another control siRNA was directed against the nuclear gene
encoding lamin A/C (5=-CUGAGAGCCGCAGCAGCUUtt-3= [lowercase letters indicate nucleotide overhangs]).
Antibodies, inhibitors, and other reagents. The polyclonal antibodies used were anti-mTor (catalog no. 2972; Cell Signaling), antiphospholipase C-␥1 (catalog no. sc-81; Santa Cruz Biotechnology), antiRab5c (product no. HPA003426; Sigma-Aldrich), and anti-SWAP70
(catalog no. sc-81991; Santa Cruz Biotechnology). The monoclonal antibodies used were anti-GIT1 (catalog no. 611396; BD Biosciences), antiPDK1 (catalog no. 611070; BD Biosciences), anti-PSCD2 (anti-ARNO)
(clone 6H5; product no. WH0009266M2; Sigma-Aldrich), and anti-␣tubulin (catalog no. T5168; Sigma-Aldrich). Horseradish peroxidase
(HRPO)-conjugated secondary antibodies were from Jackson Immunolabs.
Transfection of HeLa cells with siRNA. A total of 1.5 ⫻ 104 HeLa cells
were seeded into wells of 24-well plates and were grown for approximately
24 h. Transfection with siRNA and the lipid reagent LF2000 (Invitrogen)
was carried out as described previously (24, 34). In the experiments for
which results are shown in Fig. 2 to 4, HeLa cells were transfected with
pools of three different siRNA molecules for each target gene, except in the
case of ILK or HRAS. Targeting of ILK or HRAS involved transfection with
a pool of two siRNAs or a single siRNA, respectively. The two or three
siRNAs used in each pool are numbered 1, 2, and 3 in Table S1 in the
supplemental material. In the case of each siRNA pool (or of the single
siRNA for HRAS), the final total concentration of siRNA was 100 nM.
Control conditions for the experiments for which results are shown in Fig.
2 to 4 included mock transfection in the absence of siRNAs, transfection
with 100 nM either of two “nontargeting control” (NTC) siRNAs, and
transfection with a siRNA directed against the lamin A/C gene. For experiments involving single siRNA molecules (see Fig. 5), siRNAs were used at
a final concentration of 100 nM. Control experiments employing a 3-(4,5dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay (63) indicated that control siRNAs or siRNA pools targeting each of
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the 64 target genes shown in Table 1 and Table S1 in the supplemental
material did not affect the viability of HeLa cells 48 h after transfection.
Real-time PCR analysis. HeLa cells in 24-well plates were used for
analysis of gene expression about 48 h after transfection with siRNAs.
Cells were washed twice in phosphate-buffered saline (PBS), and a
TaqMan Gene Expression Cells-to-CT kit (Applied Biosystems) was used
to prepare cell lysates and cDNA. When lysates were prepared, DNase was
included in order to eliminate genomic DNA. In each experiment, a single
sample of cells was used for each condition involving no siRNA, a control
siRNA, or siRNAs targeting a particular human gene. Real-time PCR was
performed in triplicate on each cDNA sample using an ABI 7500 or ABI
7900 instrument (Applied Biosystems). The TaqMan gene expression assay probes used for each of the 64 target genes in the human type IA PI
3-kinase pathway are listed in Table S1 in the supplemental material. Each
of these probes spans exon-exon junctions and should not detect genomic
DNA. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene
(gene expression assay Hs99999905_m1; Applied Biosystems) was used as
an endogenous control. Threshold cycle (CT) values for the 64 target genes
ranged from 23 to 32 in the various experiments. CT values for the
GAPDH endogenous controls were typically between 18 and 19. Data
were analyzed by the comparative CT method (57), whereby CT values for
target gene expression were normalized to those for GAPDH. Relative
quantity (RQ) values were calculated as 2⫺⌬⌬CT. To obtain the relative
expression values shown in Fig. 2 to 4, the RQ values in a given experiment
were normalized to the value in cells treated with nontargeting control
siRNA 1 (NTC1). The relative expression values in Fig. 5 were obtained by
normalization to RQ values in cells mock transfected in the absence of
siRNA (“no-siRNA” condition). The data in Fig. 2 to 5 are means ⫾
standard errors of the means (SEM) from 3 to 7 independent experiments,
depending on the gene and siRNA condition.
For 10 of the 64 human genes analyzed, expression could not be reliably detected by using real-time PCR and the available probe (see Tables
S1 and S2 in the supplemental material). In these situations, the CT values
obtained for the target genes ranged from 36 to undetectable. Control
experiments with lysates that had not been subjected to reverse transcription yielded CT values from 36 to undetectable for the 64 genes. On the
basis of these control experiments, any gene producing CT values of 36 or
greater, by use of reverse-transcribed lysates, was considered to be expressed at levels too low for detection using the available probe. These
genes either were not expressed in HeLa cells, were expressed at levels
below the limit of detection of real-time PCR, or possibly were incapable
of being detected because of a flaw in the probe design.
Bacterial entry assays. HeLa cells were used for bacterial infections
approximately 48 h after transfection with siRNA. Gentamicin protection
assays to measure the entry of Listeria (see Fig. 2B, 3B, 4B, and 5) were
performed by infecting cells for 1 h in the absence of gentamicin and then
incubating them in DMEM with 20 g/ml gentamicin for 2 h as described
previously (24, 78). Entry experiments involving HeLa cells transfected
with siRNA pools (Fig. 2 to 4) or single siRNAs (Fig. 5) were performed 3
to 7 times, depending on the target gene. The entry efficiency was first
expressed as the percentage of the bacterial inoculum that survived gentamicin treatment. To obtain the relative entry values shown in Fig. 2 to 4,
the absolute percentages in a given experiment were normalized to the
values for cells treated with NTC1. The relative entry values in Fig. 5 were
obtained by normalization to the percentages for cells mock transfected in
the absence of siRNA (“no-siRNA” condition).
Western blotting and immunoprecipitation. Approximately 48 h after transfection with siRNA, HeLa cells were solubilized in radioimmunoprecipitation assay (RIPA) buffer (1% Triton X-100, 0.25% sodium
deoxycholate, 0.05% sodium dodecyl sulfate [SDS], 50 mM Tris-HCl [pH
7.5], 2 mM EDTA, 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride
[PMSF], and 10 mg/liter each of aprotinin and leupeptin). Western blotting and detection using ECL (enhanced chemiluminescence) or ECL Plus
reagents (GE Healthcare) were performed as described previously
(46, 78).
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Statistical analysis. Statistical analysis was performed using Prism
(version 5.0a; GraphPad Software). For comparison of data from three or
more conditions, analysis of variance (ANOVA) was performed. The
Tukey-Kramer test was used as a posttest. A P value of 0.05 or lower was
considered significant.

RESULTS

Construction of a siRNA library targeting components of the
type IA PI 3-kinase pathway. In order to better understand the
mechanism of InlB-mediated internalization of Listeria, we used
RNAi to target human genes encoding proteins that participate in
type IA PI 3-kinase signaling. A literature search was performed to
compile a list of 64 host genes whose products are involved in
signal transduction mediated by type IA PI 3-kinase (Table 1).
This list was then used to construct a short interfering RNA
(siRNA) library, which was screened for effects on target host gene
expression and Listeria entry. The human epithelial cell line HeLa
was used for these studies, since this cell line is readily transfected
and has been used extensively to study InlB-mediated entry (5, 24,
34, 85). When the list of genes to be targeted by RNAi was assembled, those encoding neuronal or lymphocyte-specific proteins
unlikely to be expressed in HeLa cells were excluded.
The human genes in the siRNA library were grouped into three
categories, depending on the relationships of their protein products to type IA PI 3-kinase and its lipid products PI(3,4,5)P3
and/or PI(3,4)P2 (Table 1; Fig. 1). A brief description of the categories follows. Category I contained 15 genes encoding proteins
that are known to interact physically with catalytic and/or regulatory subunits of type IA PI 3-kinase. Some of these proteins,
namely, Ras GTPases, PI 3-kinase-interacting protein 1, and
PTK2/FAK, control PI 3-kinase catalytic activity (12, 17, 97).
These proteins therefore act upstream of PI 3-kinase. Other proteins, for example, Rab4 and Rab5 GTPases, have biochemical
activities that are regulated by type IA PI 3-kinase (15). These
proteins might act downstream of the lipid kinase. For the remaining category I genes, insufficient information was available to
propose where their protein products might act with regard to PI
3-kinase. Of these proteins, APPL and Cbl function at least partly
as adaptor proteins (43, 61, 83), and their roles might lie in connecting the PI 3-kinase pathway to other signaling pathways. Category II comprised 33 genes encoding proteins known to bind
directly to PI(3,4,5)P3 and/or PI(3,4)P2. For most of these proteins, phosphoinositide binding is mediated by one or more pleckstrin homology (PH), Phox homology (PX), or DHR1 domains
(54) (Table 1). A few category II gene products (e.g., GIT1, GIT2,
SWAP70) bind PI(3,4,5)P3 through regions that are uncharacterized or that do not resemble other known protein-lipid interaction domains (79, 88). Category III was composed of 16 genes
whose products are indirectly regulated by type IA PI 3-kinase
(Table 1). The scope of category III genes was not meant to be
exhaustive. Instead, we focused on genes encoding substrates or
effectors of some well-characterized direct targets of PI 3-kinase.
Examples include isoforms of protein kinase C (PKC) (53, 74),
protein kinase N (substrates of the kinase PDK1) (64), or PAK
kinases (substrates of PDK1) (30) and mTor (a kinase indirectly
regulated by Akt proteins) (91).
RNAi-based screen. siRNAs that target the 64 genes encoding
components of the type IA PI 3-kinase pathway were designed (see
Table S1 in the supplemental material). For the vast majority of
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these genes (62 of 64), three different siRNAs were made and were
combined into pools to test for effects on host target gene expression and Listeria entry. For the ILK gene, a pool of two siRNAs was
used. The rationale for using a pooling approach was that screening of multiple siRNAs together might increase the probability of
effectively silencing target gene expression in situations in which
not all of the individual siRNAs are potent. For one of the host
genes (HRAS), only one siRNA was used. This siRNA effectively
inhibited gene expression (see below).
siRNA pools (or, for HRAS, a single siRNA) were transfected
into HeLa cells. As controls, cells were mock transfected in the
absence of siRNA or were transfected with a control “nontargeting” siRNA (referred to as NTC1) that has two or more
mismatches with all known human mRNA transcripts. Approximately 48 h posttransfection, gene expression was assessed by realtime PCR (see Materials and Methods). Of the 64 genes selected
for analysis, 47 displayed statistically significant reductions in
gene expression (due to targeting siRNAs) relative to expression
under control conditions (Fig. 2A, 3A, and 4A). For 10 of the 64
genes, expression could not be reliably detected by real-time PCR
using the available probes (see Materials and Methods and Table
S2 in the supplemental material). Effective antibodies against the
product of one of these genes, PLC-␥1, were commercially available. Western blotting indicated depletion of PLC-␥1 protein (Fig.
3Aii). For eight of the genes targeted, expression was detected by
real-time PCR, but siRNA pools targeting these genes did not reduce
expression (see Table S2). In summary, of the 64 genes initially selected for silencing, 47 exhibited substantial RNAi-mediated reductions in expression at the mRNA or protein level. None of the siRNA
conditions targeting these 47 genes affected cell growth or viability, as
assessed by MTT assays (63) (data not shown).
The 47 genes whose expression was inhibited by siRNA were
also examined for roles in Listeria entry. Internalization of Listeria
into transfected HeLa cells was measured by gentamicin protection assays, in parallel with the gene expression studies (Fig. 2B,
3B, and 4B). Control conditions for the entry experiments included the absence of siRNAs and the presence of NTC1, used in
the gene expression analyses. Additional controls were another
nontargeting siRNA (NTC2) and a siRNA capable of silencing the
nuclear protein lamin A/C. siRNAs against 21 of the type IA PI
3-kinase pathway genes resulted in statistically significant changes
in Listeria entry from that with the controls (Fig. 2B, 3B, and 4B).
For 19 of these genes, siRNAs reduced entry, suggesting a positive
role in bacterial uptake. The extent of inhibition of entry ranged
from ⬃70 to 95%, depending on the host gene targeted. As a
reference, under the same cell growth and control transfection
conditions, a bacterial mutant in which the inlB gene is deleted
enters HeLa cells at a frequency about 90% lower than that of the
isogenic inlB-positive strain (34). For two of the human genes
targeted in the RNAi screen (KRAS2 and DOCK1), siRNAs augmented the efficiency of internalization, consistent with a negative
role. The 21 host genes implicated in bacterial entry encode 3
proteins that bind to catalytic or regulatory subunits of PI 3-kinase
(Fig. 2), 12 proteins that interact with PI(3,4,5)P3 and/or
PI(3,4)P2 (Fig. 3), and 6 proteins that are indirectly regulated by PI
3-kinase (Fig. 4). Collectively, the gene expression and bacterial
entry results presented in Fig. 2 to 4 indicate that several members
of the type IA PI 3-kinase pathway play important roles in InlB-
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TABLE 1 Genes targeted in the siRNA library
Gene category and name

GenBank
accession no.

Category I. Genes encoding
proteins that bind
subunits of type IA
PI 3-kinase
Rab GTPase genes
RAB4A
NM_004578

Protein namea

Biochemical activityb

Biological function(s)

Reference(s)

Rab4a

Rab GTPase; binds p85 regulatory
subunit of PI 3-kinase
Rab GTPase; binds p85 regulatory
subunit of PI 3-kinase
Rab GTPase; binds p85 and p110
subunits of PI 3-kinase
Rab GTPse; binds p85 and p110
subunits of PI 3-kinase
Rab GTPsae; binds p85 and p110
subunits of PI 3-kinase

Receptor recycling, exocytosis

15

Receptor recycling, exocytosis

15

Ras GTPase; binds and activates
p110 catalytic subunit of PI
3-kinase
Ras GTPase; binds and activates
p110 catalytic subunit of PI
3-kinase
Ras GTPase; binds and activates
p110 catalytic subunit of PI
3-kinase
Ras GTPase; binds and activates
p110 catalytic subunit of PI
3-kinase
Ras GTPase; binds and activates
p110 catalytic subunit of PI
3-kinase

Actin cytoskeleton, cell growth

12

Actin cytoskeleton, cell growth

12

Actin cytoskeleton

12

Actin cytoskeleton, cell growth

12

Actin cytoskeleton

12

Adaptor protein; binds p110
E3 ubiquitin ligase; binds p85
regulatory subunit of PI
3-kinase
Component of adherens
junctions; binds p85 regulatory
subunit of PI 3-kinase
Transmembrane protein
containing kringle motifs;
binds and inhibits p110
catalytic subunit of PI 3-kinase
Cytosolic tyrosine kinase; binds
p85 regulatory subunit of PI
3-kinase, stimulates PI 3-kinase
activity

Enhancer of Akt1 activation
Ubiquitination, receptor
trafficking, actin cytoskeleton

61
43, 83

Cell-cell junctions, transcriptional
regulation

90

Apoptosis

97

Cell adhesion and migration

17

RAB4B

NM_016154

Rab4b

RAB5A

NM_004162

Rab5a

RAB5B

NM_002868

Rab5b

RAB5C

NM_201434

Rab5c

NM_004985

H-Ras

KRAS2

NM_004985

Ki-Ras2

MRAS

NM_012219

M-Ras/R-Ras3

NRAS

NM_002524

N-Ras

RRAS2

NM_012250

R-Ras2/TC21

Miscellaneous
APPL
CBL

NM_012096
NM_005188

APPL
Cbl

CTNNB1

NM_001904

Beta-catenin

PIK3IP1

NM_052880

PI 3-kinase-interacting
protein 1

PTK2

NM_153831

FAK/PTK2

NM_005163

Akt1/protein kinase B1

AKT2

NM_001626

Akt2/protein kinase B2

ILK

NM_004517

Integrin-linked kinase

Ras GTPase genes
HRAS

Category II. Genes
encoding proteins
that bind
PI(3,4,5)P3 and/or
PI(3,4)P2
Ser/Thr kinases
AKT1

Endocytosis (formation and fusion 15
of clathrin-coated vesicles)
Endocytosis (formation and fusion 15
of clathrin-coated vesicles)
Endocytosis (formation and fusion 15
of clathrin-coated vesicles)

Cell survival, growth, motility
Serine/threonine kinase;
substrates include BAD,
forkhead transcription factors,
GSK-␣, GSK-␤, ERM proteins;
PH domain binds PI(3,4)P2
and PI(3,4,5)P3
Serine/threonine kinase;
Cell survival, growth, motility,
substrates likely the same as
insulin-induced glucose uptake,
those of Akt1; PH domain
tumorigenesis
binds PI(3,4)P2 and PI(3,4,5)P3
Serine/threonine kinase;
Integrin-mediated cell adhesion
substrates include MLC-20 and
and survival
MYPT1; PH domain binds
PI(3,4,5)P3

49, 58

49

38

(Continued on following page)
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TABLE 1 (Continued)
Gene category and name
PDPK1

Regulators of Arf
GTPases
ARAP3

GenBank
accession no.

Protein namea

Biochemical activityb

NM_002613

PDK1

Serine/threonine kinase;
Cell survival, growth, motility,
substrates include Akt, protein
insulin signaling, T-cell
kinase C (PKC isoforms),
differentiation
PAK1, PAK2, p70S6 kinase,
and SGK1; PH domain binds
PI(3,4)P2 and PI(3,4,5)P3

NM_022481

ARAP3/centaurin ␦-3

CENTA1

NM_006869

CENTD1

NM_139182

CENTD2

NM_015242

GIT1

NM_014030

GIT2

NM_057169

PSCD1

NM_004762

PSCD2

NM_017457

PSCD3

NM_004227

Regulators of Rac, and/
or Cdc42 GTPases
ARHGAP9
ARHGEF6

NM_004840

DAPP1

NM_014395

Rho-type GTPaseactivating protein 9
␣-PIX/Rac/Cdc42 GEF
6/Cool-2
DAPP1/Bam32

DEPDC2
DOCK1

NM_024870
NM_001380

P-REX2/DEPDC2
Dock180

SOS1
SWAP70
TIAM1

NM_005633
NM_015055
NM_003253

Sos1
SWAP70
Tiam1

VAV2

NM_003371

Vav2

VAV3

NM_006113

Vav3

NM_006506

Gap1m

NM_007368

Gap1/IP4BP

Regulators of Ras
GTPases
RASA2
RASA3

NM_032496

GAP for Arf6 and RhoA; binds
PI(3,4,5)P3 through PH
domains
Centaurin ␣-1
GAP for Arf6; binds PI(3,4,5)P3,
probably through PH
domain(s)
ARAP2/centaurin ␦-1
GAP for Arf6; PI(3,4,5)P3
stimulates GAP activity,
possibly by binding PH
domain(s)
ARAP1/centaurin ␦-2
GAP for Arf1, Arf5, RhoA, and,
Cdc42; PH domain binds
PI(3,4,5)P3
GIT1
GAP for Arf1, Arf2, Arf3, Arf5,
and Arf6; PI(3,4,5)P3 stimulates
GAP activity
GIT2
GAP for Arf1, Arf2, Arf3, Arf5,
and Arf6; PI(3,4,5)P3 stimulates
GAP activity
Cytohesin-1/PSCD1
GEF for Arf1 and Arf3; PH
domain binds PI(3,4,5)P3
ARNO/cytohesin-2,
GEF for Arf1 and Arf6; PH
PSCD2
domain binds PI(3,4,5)P3
Grp1/cytohesin-3/PSCD3 GEF for Arf1, Arf3, and Arf6; PH
domain binds PI(3,4,5)P3

Biological function(s)

Reference(s)
3

Actin cytoskeleton, cell motility

51

Actin cytoskeleton, cell migration

86

Actin cytoskeleton, focal adhesions 93

Golgi structure, actin cytoskeleton 62

Actin cytoskeleton, focal
adhesions, membrane
trafficking
Actin cytoskeleton, focal
adhesions, membrane
trafficking
Integrin-mediated cell adhesion

41, 88

Actin cytoskeleton, membrane
trafficking, integrin recycling
Membrane trafficking, Golgi
function, cell adhesion

26, 87

GAP for Cdc42 and Rac1; PH
domain binds PI(3,4,5)P3
GEF for Rac and Cdc42

Cell adhesion

13

Cell adhesion

94

Adaptor protein; enhances Rac
activity; PH domain binds
PI(3,4)P2 and PI(3,4,5)P3
GEF for Rac
GEF for Rac; DHR1 domain binds
PI(3,4,5)P3
GEF for Rac and Ras
GEF for Rac
GEF for Rac; PH domain binds
PI(3,4,5)P3
GEF for Rac; PH domain is
thought to bind PI(3,4,5)P3
GEF for Rac; PH domain is
thought to bind PI(3,4,5)P3

Actin cytoskeleton

28

Actin cytoskeleton
Actin cytoskeleton, cell motility,
phagocytosis
Actin cytoskeleton, cell growth
Actin cytoskeleton
Actin cytoskeleton, cell motility

25
20

Actin cytoskeleton

36

Actin cytoskeleton

36

Cell growth inhibitor
GAP for Ras; PH domain binds
PI(3,4,5)P3
GAP for Ras and Rap; PH domain Cell growth inhibitor
binds PI(3,4,5)P3

41, 88

26, 50

26, 55

72
79
72

92
92
(Continued on following page)
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TABLE 1 (Continued)
GenBank
accession no.

Protein namea

Biochemical activityb

Biological function(s)

Reference(s)

NM_002660

PLC-␥1

NM_002662

Phospholipase D1

Actin cytoskeleton, cell growth,
phagocytosis
Actin cytoskeleton, membrane
trafficking

32

PLD1

PLD2

NM_002663

Phospholipase D2

Converts PI(4,5)P2 to IP3; PH
domain binds PI(3,4,5)P3
Converts phosphatidylcholine to
phosphatidic acid, activated by
PI(3,4,5)P3 or PI(3,4)P2; PH
domain binds PI(3,4)P2
Converts phosphatidylcholine to
phosphatidic acid, activated by
PI(3,4,5)P3 or PI(3,4)P2; PH
domain binds PI(3,4)P2
Adaptor protein; PH domain
binds PI(3,4)P2

Actin cytoskeleton, membrane
trafficking

71

Actin cytoskeleton, inhibition of
insulin and PI 3-kinase
pathways

27

Tec family tyrosine kinase; PH
domain binds PI(3,4,5)P3
Actin-dependent motor protein;
PH domains bind PI(3,4,5)P3
PX domain binds PI(3,4,5)P3
PX domain binds PI(3,4)P2

Cell growth, motility, apoptosis

80

Contractility, phagocytosis

21, 69

Endocytosis, receptor trafficking
Endocytosis, receptor recycling
from endosomes to the Golgi

96
60

Ser/Thr kinase; regulated by Akt;
substrates include Akt, PKC-␣,
PKC-␦, p70S6 kinase, SGK1
Regulates glycogen synthase;
substrate of Akt proteins
Regulates glycogen synthase;
substrate of Akt proteins
Ser/Thr kinase; phosphorylated
by PDK1
Ser/Thr kinase; phosphorylated
by PDK1
Ser/Thr kinase; phosphorylated
by PDK1; substrates include
␣-actinin, adducin, and
cortactin
Ser/Thr kinase; phosphorylated
by PDK1; substrates include
␣-actinin, adducin, and
cortactin
Ser/Thr kinase; phosphorylated
by PDK1 and mTor; substrates
include MARCKS, ERM
proteins, adducin
Ser/Thr kinase; phosphorylated
by PDK1 and mTor; substrates
include MARCKS, ERM
proteins, adducin
Ser/Thr kinase; phosphorylated
by PDK1; substrates include
MARCKS, ERM proteins,
adducin

Regulation of protein synthesis,
cell migration

33, 75, 91

Cell survival, tumorigenesis,
regulation of gene expression
Cell survival, tumorigenesis,
regulation of gene expression
Actin cytoskeleton, cell migration

75

Actin cytoskeleton, cell migration

30

Gene category and name
Lipid-modifying
enzymes
PLCG1

Adaptor protein
PLEKHA1
Miscellaneous
BMX

NM_001001974 PLEKHA1/TAPP1

NM_203281

Bmx/Etk

MYOX

NM_012334

Myosin X

SNX1
SNX5

NM_003099
NM_152227

Sorting nexin-1
Sorting nexin-5

Category III. Genes
encoding proteins
indirectly regulated
by type IA PI
3-kinase
FRAP1
NM_004958

mTor/FRAP1

GSK3A

NM_019884

GSK3B

NM_002093

PAK1

NM_002576

Glycogen synthase
kinase-3␣
Glycogen synthase
kinase-3␤
PAK1

PAK2

NM_002577

PAK2

PKN1

NM_213560

Protein kinase N1

PKN2

NM_006256

Protein kinase N2

PRKCD

NM_006254

PKC-␦

PRKCE

NM_005400

PKC-

PRKCG

NM_002739

PKC-␥

71

75
30

Actin cytoskeleton, cell migration, 64
membrane trafficking,
exocytosis
Actin cytoskeleton, cell migration, 64
cell adhesion

Actin cytoskeleton; cell migration

53, 74

Actin cytoskeleton; cell migration

53, 74

Actin cytoskeleton; cell migration

53, 74

(Continued on following page)
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TABLE 1 (Continued)
GenBank
accession no.

Protein namea

Biochemical activityb

Biological function(s)

Reference(s)

PRKCI

NM_002740

PKC-

Actin cytoskeleton

53, 74

PRKCQ

NM_006257

PKC-

Actin cytoskeleton; cell migration

53, 74

PRKCZ

NM_002744

PKC-

Actin cytoskeleton, cell polarity

53, 74

RPS6KA1

NM_002953

P70S6 kinase 1/RSK1

Regulation of translation, cell
growth

75

RPS6KA3

NM_004586

P70 S6 kinase 2/RSK2

Regulation of translation, cell
growth

75

SGK1

NM_005627

Serum/glucocorticoidregulated kinase 1

Ser/Thr kinase; substrate of
PDK1; substrates include
MARCKS, ERM proteins,
adducin
Ser/Thr kinase; phosphorylated
by PDK1; substrates include
MARCKS, ERM proteins,
adducin
Ser/Thr kinase; phosphorylated
by PDK1; substrates include
MARCKS, ERM proteins,
adducin
Substrate of PDK1;
phosphorylates several
transcription factors, including
SRF and c-Fos
Substrate of PDK1;
phosphorylates several
transcription factors, including
SRF and c-Fos
Ser/Thr kinase; phosphorylated
by PDK1 and mTor; substrates
include NEDD4L and FOXO3A

Cell survival, ion transport

10

Gene category and name

a
b

FAK, focal adhesion kinase; PTK2, protein tyrosine kinase 2; PDK1, 3-phosphoinositide-dependent kinase 1; PLC-␥1, phospholipase C-␥1; PKC, protein kinase C.
GAP, GTPase-activating protein; GEF, guanine nucleotide exchange factor.

mediated Listeria internalization. We comment below on known
cellular functions of key host proteins that emerged from the
RNAi screen (see Discussion). Also discussed are possible mechanisms by which some of the PI 3-kinase pathway proteins might
promote Listeria entry.

FIG 1 Human type IA PI 3-kinase pathway components targeted in the
RNAi-based screen. During infection with Listeria, host type IA PI 3-kinase
is activated downstream of the Met receptor and plays a critical role in
bacterial internalization (45, 46, 78). Type IA PI 3-kinase uses PI(4,5)P2 as
a substrate and produces the lipid second-messenger product PI(3,4,5)P3
(11, 31). PI(3,4)P2 is another second messenger, which is generated from
PI(3,4,5)P3 by phosphatases (11). The RNAi-based screen performed in
this study targeted three categories of host genes encoding proteins that act
on the type IA PI 3-kinase signaling pathway. Category I genes encode
proteins that interact with the 85-kDa regulatory and/or 110-kDa catalytic
subunit of PI 3-kinase. Category II genes code for proteins that bind to the
PI 3-kinase lipid products PI(3,4,5)P3 and/or PI(3,4)P2. Category III genes
encode products that are indirectly controlled by type IA PI 3-kinase.
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Addressing possible off-target effects of siRNAs. Although
RNAi is a powerful method of genetic analysis, a potential weakness of this approach is the occurrence of “off-target” effects (22).
The term “off target” refers to a situation in which a siRNA affects
an mRNA other than the desired target mRNA. One common
method of minimizing the possibility of off-target effects is to
confirm that several different siRNA molecules recognizing distinct regions in a given mRNA cause the same biological phenotype (22). We selected 8 of the 21 human genes implicated in
Listeria entry (Fig. 2 to 4) and tested whether multiple siRNAs
inhibiting target gene expression also impaired bacterial uptake.
The genes selected were the category I gene RAB5C, category II
genes PSCD1, DAPP1, GIT1, PDPK1, and SWAP70, and category
III genes FRAP1 and PRKCZ. The multiple siRNAs used consisted
of the three individual components of the siRNA pools employed
in the experiments for which results are shown in Fig. 2 to 4. In
some cases (e.g., PDPK1 and FRAP1), a fourth siRNA was also
tested. The data are presented in Fig. 5. Importantly, for each of
the eight genes selected, three siRNAs with unique sequences inhibited both bacterial entry and gene expression at the mRNA
level. For five of these eight human genes, effective antibodies were
commercially available. We used these antibodies to confirm the
inhibition of expression at the protein level (Fig. 6). Taken together, the findings in Fig. 5 and 6 indicate that off-target effects
for the eight selected host genes are unlikely. The data support the
idea that these genes have bona fide roles in Listeria internalization.
In previous work, we confirmed that multiple siRNAs targeting
the human CENTD1 gene (encoding the ARAP2 protein) impair
gene expression at the mRNA and protein levels and also block
Listeria entry (34). Based on the present study and previous work,
we conclude that our RNAi-based screen has identified at least
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FIG 2 Effects of siRNAs targeting category I host genes on gene expression and InlB-mediated Listeria entry. (A) Inhibition of host gene expression by siRNA
pools. HeLa cells were transfected with siRNA pools targeting the indicated category I host genes. As controls, cells were transfected with a nontargeting control
siRNA (NTC1) or were mock transfected in the absence of siRNAs (none). Approximately 48 h after transfection, cell lysates were prepared. Gene expression was
analyzed by real-time PCR. Relative gene expression values were determined as described in Materials and Methods. Data are means ⫾ SEM for 3 to 5
experiments, depending on the siRNA condition. Statistical analysis by ANOVA gave a P value of ⬍0.0001. *, P ⬍ 0.05 relative to the NTC1 or no-siRNA control
(by the Tukey-Kramer posttest). (B) Impact of siRNA pools on Listeria internalization into host cells. HeLa cells were transfected with siRNA pools directed
against the indicated category I host gene. As controls, cells either were transfected with one of two nontargeting control siRNAs (NTC1, NTC2) or with a siRNA
directed against lamin A/C or were mock transfected in the absence of siRNAs (none). About 48 h posttransfection, bacterial entry was assessed by using
gentamicin protection assays. Relative entry values were obtained by normalization to entry in cells treated with the NTC1 control, as described in Materials and
Methods. Data are means ⫾ SEM. Results for siRNAs targeting category I genes are from 3 to 7 experiments, depending on the siRNA condition. Data obtained
under the no-siRNA (none), NTC2, or lamin A/C siRNA control condition are from 46, 13, or 13 experiments, respectively. Statistical analysis by ANOVA gave
a P value of ⬍0.0001. *, P ⬍ 0.05 relative to the NTC1, NTC2, lamin A/C, or no-siRNA control (by the Tukey-Kramer posttest).

nine human genes that are required for efficient InlB-mediated
entry of Listeria.
DISCUSSION

In this work, we describe an RNAi screen that led to the identification of at least nine human genes encoding proteins in the type
IA PI 3-kinase pathway that play important roles in Listeria entry.
One of the genes identified from the screen, RAB5C, codes for a
protein that interacts with regulatory and catalytic subunits of
type IA PI 3-kinase (15, 18, 52). Six of the host genes, CENTD1,
PSCD2, DAPP1, GIT1, PDPK1, and SWAP70, encode proteins
that bind directly to the PI 3-kinase lipid products PI(3,4,5)P3
and/or PI(3,4)P2 (3, 28, 79, 87, 88, 93). Two of the genes identified
from the screen, FRAP1 and PRKCZ, code for proteins that are
indirectly regulated by PI 3-kinase (3, 39, 75). In addition to the
nine host genes described above, it seems likely that other members of the type IA PI 3-kinase signaling pathway are involved in
the InlB-dependent entry of Listeria. The results obtained with
siRNA pools implicated 21 different human genes in bacterial in-
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ternalization (Fig. 2 to 5). Nine of these 21 genes were further
examined for roles in Listeria entry by testing multiple individual
siRNAs (Fig. 6). The results indicated that off-target effects were
unlikely and that the nine host genes therefore play important
roles in bacterial uptake. Future work using single siRNAs will
determine which of the remaining 12 host genes have bona fide
functions in Listeria entry.
For 26 of the host genes targeted in our study, siRNA-mediated
inhibition of expression failed to affect Listeria entry in a statistically significant fashion. These findings suggest that many of these
26 genes do not play important roles in bacterial internalization, at
least not under the conditions employed in our work. It is worth
noting that 2 of these 26 human genes, PLD2 and CBL, have been
implicated in InlB-mediated uptake previously. In the case of
PLD2, an earlier study used a cell line other than HeLa (37). The
apparent discrepancy between our data and the prior study is most
likely due to cell line differences. Previous siRNA studies targeting
CBL in HeLa cells suggested that this host gene is needed for efficient Listeria entry (85). In our work, siRNAs directed against CBL
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FIG 3 Effects of siRNAs directed against category II host genes on human gene expression and internalization of Listeria. (A) Inhibition of host gene expression.
HeLa cells were transfected with siRNA pools targeting the indicated category II host genes. Control transfection conditions and analysis of gene expression were
carried out as described in the legend for Fig. 2. (i) Gene expression was analyzed by real-time PCR for all but one of the genes. (ii) In the case of PLCG1 (encoding
PLC-␥1 protein), gene expression was assessed by Western blotting, since the probe did not detect expression (see Materials and Methods). Data are means ⫾
SEM for 3 to 5 experiments, depending on the siRNA condition. Statistical analysis by ANOVA gave a P value of ⬍0.0001. *, P ⬍ 0.05 relative to the NTC1 or
no-siRNA control (by the Tukey-Kramer posttest). (B) Effects of siRNA pools on Listeria internalization. HeLa cells were transfected with siRNA pools directed
against the indicated category II host gene. Control transfection conditions and measurement of bacterial entry were carried out as described in the legend for Fig.
2. Data for siRNAs targeting category II genes are means ⫾ SEM for 3 to 5 experiments. Data obtained under the no-siRNA (none), NTC2, or lamin A/C siRNA
control condition are from 46, 13, or 13 experiments, respectively. Statistical analysis by ANOVA gave a P value of ⬍0.0001. *, P ⬍ 0.05 relative to the NTC1,
NTC2, lamin A/C, or no-siRNA control (by the Tukey-Kramer posttest).
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FIG 4 Effects of siRNAs targeting category III host genes on human gene expression and entry of Listeria. (A) Inhibition of host gene expression. HeLa cells were
transfected with siRNA pools targeting the indicated category III host genes. Control transfection conditions were those described in the legend for Fig. 2. For
experiments with siRNAs targeting category III genes, data are means ⫾ SEM for 3 to 5 experiments, depending on the siRNA condition. Statistical analysis by
ANOVA gave a P value of ⬍0.0001. *, P ⬍ 0.05 relative to the NTC1 or no-siRNA control (by the Tukey-Kramer posttest). (B) Impact of siRNA pools on Listeria
entry. HeLa cells were transfected with siRNA pools directed against the indicated category III host genes. Control transfection conditions and measurement of
bacterial entry were carried out as described in the legend for Fig. 2. Data for siRNAs targeting category III genes are means ⫾ SEM for 3 to 7 experiments. Data
obtained under the no-siRNA (none), NTC2, or lamin A/C siRNA control condition are from 46, 13, or 13 experiments, respectively. Statistical analysis by
ANOVA gave a P value of ⬍0.0001. *, P ⬍ 0.05 relative to the NTC1, NTC2, lamin A/C, or no-siRNA control (by the Tukey-Kramer posttest).

reduced Listeria internalization by approximately 70%, but the
effect was not statistically significant.
As described above, our RNAi screen identified at least nine
human genes that have important functions in InlB-mediated entry. How might these genes control the internalization of Listeria?
Below, we describe what is known about the cellular functions of
the protein products of the genes. The molecular mechanisms by
which these proteins might regulate bacterial entry are also discussed and are summarized in Fig. 7.
Rab5c. Rab5c is one of three Rab5 GTPases that control
clathrin-dependent endocytosis and early endosome fusion (14).
Results from the RNAi-based screen indicated a role for Rab5c,
but not for the Rab5a or Rab5b protein, in Listeria entry (Fig. 2, 5,
and 6). Activated Rab5 proteins bind to the p110 catalytic and p85
regulatory subunits of type IA PI 3-kinase (15, 18, 52). The interaction of Rab5 proteins with p85 results in enhanced GTP hydrolysis on Rab5 (15). These findings suggest that PI 3-kinase might
control Rab5-mediated endocytosis and/or subsequent vesicular
trafficking. Importantly, the InlB-dependent entry of Listeria requires clathrin and several other human proteins that regulate
clathrin-mediated endocytosis (85). It is possible that Rab5c
works together with the endocytic machinery previously reported
to control Listeria uptake. How might Rab5-dependent endocytosis promote bacterial entry? Recent results indicate an important
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role for Rab5 in signal transduction and actin polymerization mediated by the Met receptor (68). Activation of Met by its mammalian ligand hepatocyte growth factor (HGF) leads to the Rab5dependent stimulation of the GTPase Rac1 and subsequent actin
polymerization. Rab5 promotes the internalization of Rac1 into
endosomes, where Rac1 is then activated. Activated, endosomal
Rac1 is then delivered to specific sites on the plasma membrane,
resulting in cortical actin polymerization. Importantly, Rac1 is
needed for the InlB-mediated internalization of Listeria (4). The
recent findings with Rab5 and Met raise the possibility that one
role of Rab5c in Listeria entry might be to facilitate the localized
delivery of Rac1 to promote subsequent cytoskeletal remodeling.
Regulators of Arf GTPases (ARAP2, GIT1, ARNO). The results from the RNAi-based screen indicated that at least six host
genes encoding proteins that bind PI(3,4,5)P3 have important
functions in Listeria internalization. Three of these host proteins,
ARAP2 (encoded by CENTD1), GIT1, and ARNO (encoded by
PSCD2), are regulators of small GTPases of the Arf family (26).
ARAP2 and GIT1 are GTPase-activating proteins (GAPs) capable
of antagonizing various Arf GTPases (26). Binding of PI(3,4,5)P3
to ARAP2 or GIT1 enhances the GAP activities of these proteins
(88, 93). These findings indicate that type IA PI 3-kinase can inhibit Arf GTPases through ARAP2 and GIT1. In previous work,
we found that ARAP2 promotes Listeria entry, in part by restrain-
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FIG 5 Multiple siRNAs inhibiting target gene expression impair Listeria internalization. HeLa cells were transfected with siRNA pools or with an individual
siRNA targeting the human gene indicated in each panel. Four individual siRNAs were tested for PDPK1 and FRAP1, whereas three siRNAs were tested for all
other genes. As controls, cells either were mock transfected in the absence of siRNA (no siRNA) (open bars) or were transfected with control nontargeting siRNA
1 (NTC1) (shaded bars). (i) Effects of siRNAs on host gene expression. Gene expression was analyzed by real-time PCR. Data are means ⫾ SEM for 3 to 4
experiments, depending on the siRNA condition. ANOVA gave P values of ⬍0.0001 for RAB5C (A), PDPK1 (E), SWAP70 (F), FRAP1 (G), and PRKCZ (H),
0.0001 for GIT1 (D), 0.0003 for DAPP1 (C), and 0.0012 for PSCD2 (B). *, P ⬍ 0.05 relative to the no-siRNA or NTC1 control (by the Tukey-Kramer posttest).
(ii) Effects of siRNA pools on Listeria internalization. Data are means ⫾ SEM for 3 to 7 experiments, depending on the siRNA condition. Statistical analysis by
ANOVA gave P values of ⬍0.0001 for all data in all panels. *, P ⬍ 0.05 relative to the no-siRNA or NTC1 control (by the Tukey-Kramer posttest).

ing the activity of Arf6 (34). The mechanism by which ARAP2mediated inhibition of Arf6 facilitates bacterial uptake is not
known. The observation that uncontrolled activation of Arf6 leads
to the sequestration of cholesterol and PI(4,5)P2 in internal membranes (9, 65) prompted a hypothesis that ARAP2 might maintain
the normal plasma membrane localization of lipids critical for
Listeria uptake (34). It is possible that GIT1, like ARAP2, promotes Listeria internalization by antagonizing Arf6. This idea
would imply that neither ARAP2 nor GIT1 alone is sufficient to
fully inactivate Arf6. Alternatively, GIT1 could act through regulation of other Arf GTPases, such as Arf1, Arf2, Arf3, or Arf5 (41,
88). A third way in which GIT1 could mediate Listeria uptake is by
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contributing to the activation of Rac1 and/or Cdc42 GTPases.
Both Rac and Cdc42 are needed for InlB-mediated entry (4, 5).
GIT1 promotes the activation of these two GTPases by binding to
the guanine nucleotide exchange factor (GEF) ␤-PIX (41, 47).
ARNO, the third Arf regulator identified in our RNAi screen, is a
GEF that activates Arf1 or Arf6 GTPases (26). PI(3,4,5)P3 binds to
a pleckstrin homology (PH) domain in ARNO, thereby recruiting
this GEF to the plasma membrane (26, 87). In previous work, we
found that siRNA-mediated depletion of Arf6 did not impair Listeria entry (34). This finding indicates that ARNO does not mediate bacterial internalization through Arf6. It is possible that
ARNO acts on Arf1 to stimulate Listeria uptake. Experiments in-
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FIG 7 Potential mechanisms of control of Listeria entry by the type IA PI
FIG 6 Confirmation that siRNAs inhibit expression at the protein level. The
human proteins evaluated for expression are given on the left, followed by the
gene names in parentheses. HeLa cells were transfected with siRNA pools (P)
or with individual siRNAs directed against the indicated human gene. As controls, cells either were mock transfected in the absence of siRNA (⫺) or were
transfected with nontargeting control 1 siRNA (C). Approximately 48 h after
transfection, cells were solubilized in RIPA buffer. The indicated target protein
was detected by Western blotting as described in Materials and Methods. In
order to confirm equivalent loading, membranes were then stripped and were
probed a second time, with anti-tubulin antibodies.

volving RNAi-mediated depletion of Arf1 indicate an important
role for this GTPase in InlB-mediated bacterial entry (P. Le and K.
Ireton, unpublished data). Arf1 could control entry by promoting
PI(4,5)P2 synthesis through PI 4-phosphate 5-kinase (26). Alternatively or additionally, ARNO might stimulate Listeria uptake by
promoting the recycling of integrin receptors to the plasma membrane (66). Integrins contribute to signaling downstream of the
Met receptor (82) and are also needed for efficient InlB-mediated
Listeria entry (2).
SWAP70. Another PI(3,4,5)P3-interacting protein that is required for Listeria entry is SWAP70, a known direct activator of
Rac1 GTPase (79). As previously mentioned, Rac1 promotes InlBmediated entry by eliciting actin cytoskeletal changes through the
Arp2/3 complex (4, 5). SWAP70 is a Rac1 GEF whose activity is
stimulated by PI(3,4,5)P3 (79). Our findings suggest that Rac1
activation downstream of the Met receptor during Listeria entry
might be promoted by SWAP70. Apart from SWAP70, our RNAibased screen targeted several other PI(3,4,5)P3-regulated GEFs for
Rac1. The results indicated that the GEFs Dock180, SOS1, and
Vav2 are dispensable for Listeria internalization (Fig. 3).
DAPP1. The DAPP1 gene is critical for Listeria entry and encodes a PI(3,4,5)P3-binding adaptor protein. DAPP1 protein contains a PH domain that interacts with PI(3,4,5)P3, an SH2 domain,
and a tyrosine residue capable of being phosphorylated (1, 28).
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3-kinase signaling pathway. Infection of human cells with Listeria expressing
InlB results in activation of the host Met receptor and of type IA PI 3-kinase
(24, 45, 46, 78). The RNAi-based screen described in this work led to the
identification of nine human proteins involved in PI 3-kinase signaling that
play important roles in Listeria entry. Based on the biological functions of these
nine proteins reported in the scientific literature, a diagram was constructed
depicting some of the possible ways in which the host proteins could participate in bacterial uptake. Rab5c, a protein that interacts with regulatory and
catalytic subunits of type IA PI 3-kinase, could promote Listeria entry by controlling the host endocytic machinery (14, 85). ARNO, an activator of Arf
GTPases that binds directly to the PI 3-kinase product PI(3,4,5)P3, might help
maintain proper levels of integrins, a class of receptor recently found to enhance InlB-mediated entry, in the plasma membrane (2). The serine/threonine
kinase PKC- could promote Listeria internalization by controlling the actin
cytoskeleton and/or the delivery of membrane through exocytosis (7, 53, 73).
PKC- is indirectly regulated by PI 3-kinase through the master kinase PDK1,
which is a direct target of PI(3,4,5)P3 (3). mTor, a serine/threonine kinase
indirectly controlled by type IA PI 3-kinase, might promote bacterial uptake
through activation of the host proteins Rac1 and/or PKC-␣ (not shown) (75,
91). Apart from mTor, three other human proteins identified in the RNAi
screen have the potential to control Listeria entry though activation of Rac1
GTPase. These proteins, SWAP70, DAPP1, and GIT1, each bind directly to
PI(3,4,5)P3. SWAP70 is a direct activator of Rac1 and stimulates nucleotide
exchange on the GTPase (79). DAPP1 and GIT1 lack recognizable guanine
nucleotide exchange factor (GEF) domains and likely activate Rac1 indirectly.
In addition to being an indirect activator of Rac1, GIT1 is also a GTPaseactivating protein (GAP) that inhibits Arf6 GTPase (41). Along with ARAP2,
another Arf6 GAP needed for Listeria entry (34), GIT1 might restrain the
activation of Arf6, which would otherwise interfere with bacterial uptake.
Constitutively activated Arf6 alleles inhibit Listeria internalization (34) and
also induce the redistribution of cholesterol from the plasma membrane to
internal membrane compartments (65). Since plasma membrane cholesterol
is critical for InlB-mediated entry, it is possible that GIT1 and/or ARAP2 promotes Listeria uptake by maintaining proper localization of cholesterol and/or
other lipids (34).

Known functions of DAPP1 include regulation of phospholipase
C-␥ and activation of Rac1 GTPase (1, 95). The lack of a recognizable GEF domain in DAPP1 indicates that the effect on Rac1 activity is likely indirect. Our RNAi data suggested an important role
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for phospholipase C-␥1 in InlB-mediated entry (Fig. 3). Possible
ways in which DAPP1 could promote Listeria uptake include activation of PLC-␥1 and/or Rac1.
PDK1 and PKC-. The results from the RNAi screen indicated
important functions for the serine/threonine kinase PDK1 (encoded by the PDPK1 gene) in Listeria entry. PDK1 is a “master
kinase” that phosphorylates the activation loop of more than 20
serine/threonine kinases of the AGC family (3, 74). PDK1mediated phosphorylation is critical for the activity of these AGC
kinases. Our siRNA library targeted 13 genes encoding AGC kinases that are PDK1 substrates (Table 1). Eight of these 13 genes
were expressed in HeLa cells and were effectively silenced by
siRNA (Fig. 4; see also Table S1 in the supplemental material).
These eight genes were AKT1, AKT2, PRKCD (encoding PKC-␦),
PRKCG (encoding PKC-␥), PRKCZ (encoding PKC-), PKN1,
PKN2, and SGK1. The results with siRNA pools suggested that
PRKCD, PRKCZ, PKN1, and PKN2 might have important functions in Listeria internalization. Experiments with single siRNAs
confirmed that PRKCZ plays a crucial role in InlB-mediated entry.
Importantly, the product of PRKCZ, PKC-, is known to regulate
the actin cytoskeleton (35, 39, 56). Potential substrates of PKC-
include proteins that cross-link F-actin to the plasma membrane
(MARCKS and ERM proteins), actin binding proteins of the coronin family, the actin-capping protein adducin, the actinbundling protein fascin, and the anti-capping protein VASP (16,
53). PKC- could mediate Listeria entry, at least in part, by stimulating actin remodeling through phosphorylation of one or more
of these substrates. Another important activity of PKC- is the
promotion of exocytosis—the fusion of intracellular vesicles with
the plasma membrane (56, 73). Specifically, PKC- phosphorylates VAMP2, a vesicular protein that mediates vesicle docking to
the plasma membrane (7). Thus far, no role for exocytosis in Listeria entry has been described. During Fc-␥ receptor-mediated
phagocytosis in macrophages, exocytic delivery of vesicles to the
phagosome replenishes the plasma membrane that would otherwise be lost due to particle internalization (8). It is possible that
exocytosis occurs during Listeria uptake and serves a similar function. Another potential function for exocytosis could be to provide the plasma membrane needed for the extension of pseudopods around adherent bacteria.
mTor. The RNAi screen revealed a critical role for the host
protein mTor in InlB-mediated Listeria entry. mTor (encoded
by the FRAP1 gene) is a serine/threonine kinase that functions
downstream of type IA PI 3-kinase to regulate several biological processes, including translation, ribosome biogenesis, autophagy, and cytoskeletal organization (75, 91). mTor is present in two different multiprotein complexes, termed mTORC1
and mTORC2. mTORC1 controls protein synthesis, cell
growth, and autophagy. In contrast, mTORC2 regulates the
actin cytoskeleton. Many of the cellular functions of mTORC1
are inhibited by the drug rapamycin (75), whereas mTORC2 is
thought to be insensitive to this compound. Interestingly,
treatment of HeLa cells with rapamycin fails to impair InlBmediated Listeria internalization (data not shown), suggesting
that the mTor complex involved in bacterial uptake is likely
mTORC2, not mTORC1. mTORC2 is known to control the
actin cytoskeleton through phosphorylation of PKC-␣ or activation of Rac1 GTPase (91). Future work will determine
whether mTor promotes Listeria internalization through
PKC-␣ or Rac1, or via a previously unrecognized pathway.
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The RNAi-based screen described in this work represents a key
first step toward understanding how type IA PI 3-kinase promotes
InlB-mediated Listeria entry. Future studies will examine the molecular mechanisms by which the proteins encoded by the various
host genes identified in the screen control Listeria uptake. Such
work will contribute to a better understanding of how bacterial
activation of the Met receptor elicits actin cytoskeletal changes
that drive Listeria internalization. Future studies of human proteins identified from the screen also have the potential to uncover
novel host cell events needed for bacterial entry, such as localized
exocytosis (Fig. 7).
Importantly, human type IA PI 3-kinase plays a critical role in
the internalization of several microbial pathogens other than Listeria. Such microbes include bacterial pathogens that cause
anthrax (Bacillus anthracis) (67), respiratory infections (Pseudomonas aeruginosa and Chlamydia pneumoniae) (19, 48), and
food-borne disease (Campylobacter jejuni and Yersinia enterocolitica) (42, 77). Host type IA PI 3-kinase also promotes the entry of
the virus responsible for hemorrhagic fever (Ebola virus) (76) and
parasites causing Chagas’ disease (Trypanosoma cruzi) (81) or toxoplasmosis (Toxoplasma gondii) (23). To the best of our knowledge, our work is the first systematic study to identify components
of the host type IA PI-3 kinase pathway involved in infection by a
microbial pathogen. Human proteins identified as critical for Listeria entry may also be viable candidates for host factors mediating
infection by these other important pathogens.
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